Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis
Article 2022 en
Authors
FV
Fernando Valenzuela
CC
Claudia de la Cruz
CL
Cristóbal Lecaros
Abstract
1 min read
We report a large study of comorbidities, including depression, dyslipidaemia, T2DM and NAFLD, in people with psoriasis in Chile. The prevalence of comorbidities with psoriasis in Chile appears similar to that found in Western countries, and emphasizes the importance of assessing patients with psoriasis for risk factors for and presence of, comorbid disease in a multidisciplinary setting.
Julia‐Tatjana Maul, Fabienne Fröhlich, Lara Valeska Maul, Rieka Stunnenberg, Fernando Valenzuela, C. Cruz, Cristián Vera‐Kellet, Daniela Armijo, Wagner Guimarães Galvão Cesar, André Vicente Esteves de Carvalho, Johannes A. Didaskalu, Nicole Graf, Alexander Egeberg, Jashin J. Wu, Jacob P. Thyssen, Ricardo Romiti, Christopher Em Griffiths
Lis Cordingley, Pauline Nelson, Linda Davies, Darren M. Ashcroft, Christine Bundy, Carolyn Chew‐Graham, Anna Chisholm, Jamie Elvidge, Matthew Hamilton, Rachel Hilton, K. Kane, Chris Keyworth, Alison Littlewood, Karina Lovell, Mark Lunt, Helen McAteer, Dionysios Ntais, Rosa Parisi, Christina J. Pearce, Martin K. Rutter, Deborah Symmons, Helen Young, Christopher Em Griffiths
Lucas Lauder, Felix Mahfoud, Michel Azizi, Deepak L. Bhatt, Sebastian Ewen, Kazuomi Kario, Gianfranco Parati, Patrick Rossignol, Markus P. Schlaich, Koon Teo, Raymond R. Townsend, Costas Tsioufis, Michael A. Weber, Thomas Weber, Michael Böhm
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.